Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
baojun shi
(51 results)?
Melanopsin retinal ganglion cells mediate light-promoted brain development.
Cell. 2022 Aug 18;185(17):3124-3137.e15. doi: 10.1016/j.cell.2022.07.009. Epub 2022 Aug 8.
Cell. 2022.
PMID: 35944541
Free article.
The histone demethylase Kdm6b regulates the maturation and cytotoxicity of TCRαβ+CD8αα+ intestinal intraepithelial lymphocytes.
Zhang H, Hu Y, Liu D, Liu Z, Xie N, Liu S, Zhang J, Jiang Y, Li C, Wang Q, Chen X, Ye D, Sun D, Zhai Y, Yan X, Liu Y, Chen CD, Huang X, Eugene Chin Y, Shi Y, Wu B, Zhang X.
Zhang H, et al.
Cell Death Differ. 2022 Jul;29(7):1349-1363. doi: 10.1038/s41418-021-00921-w. Epub 2022 Jan 9.
Cell Death Differ. 2022.
PMID: 34999729
Free PMC article.
Item in Clipboard
Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months.
Blauvelt A, Shi N, Burge R, Atiya B, Zhu B, Somani N, Ridenour T, Lew CR, Zimmerman NM, Murage MJ.
Blauvelt A, et al.
Pharmacoecon Open. 2022 Nov;6(6):871-880. doi: 10.1007/s41669-022-00365-z. Epub 2022 Sep 26.
Pharmacoecon Open. 2022.
PMID: 36155891
Free PMC article.
Item in Clipboard
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab.
Blauvelt A, Shi N, Burge R, Malatestinic WN, Lin CY, Lew CR, Zimmerman NM, Goldblum OM, Zhu B, Murage MJ.
Blauvelt A, et al.
Patient Prefer Adherence. 2020 Mar 9;14:517-527. doi: 10.2147/PPA.S233993. eCollection 2020.
Patient Prefer Adherence. 2020.
PMID: 32210539
Free PMC article.
Item in Clipboard
Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA.
Blauvelt A, Shi N, Somani N, Burge R, Zhu B, Ridenour T, Kern S, Lew C, Zimmerman N, Murage M.
Blauvelt A, et al.
Clin Drug Investig. 2023 Mar;43(3):185-196. doi: 10.1007/s40261-022-01240-9. Epub 2023 Feb 25.
Clin Drug Investig. 2023.
PMID: 36840815
Free PMC article.
Item in Clipboard
Cite
Cite